ArticleJournal of clinical gastroenterology2015
Self-efficacy and adherence to antiviral treatment for chronic hepatitis C.
Article in Journal of clinical gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial).The patient · 2017Trial
- Modeling the effects of treatment adherence challenges on the transmission dynamics of hepatitis C virus.PloS one · 2025Article
- The Effect of Family-Centered Intervention via SMS on Life Expectancy and Self-Efficacy in Medication Regimen Compliance in Patients With Acute MI: A Randomized Clinical Trial.ARYA atherosclerosis · 2023Article
- A Comprehensive Nursing Model Combined with High-Quality Nursing Intervention for Antiviral Therapy in Patients with Chronic Hepatitis B.Evidence-based complementary and alternative medicine : eCAM · 2022Article
- Development and Evaluation of an Antiviral Agent Medication Adherence Education Program for Patients with Chronic Hepatitis C.International journal of environmental research and public health · 2020Article
- Canonical Correlation Between Self-Care Agency and Health-Related Self-Efficacy with Chronic Viral Hepatitis Patients.Osong public health and research perspectives · 2019Article
- Content Validity and Reliability of a Self-Report Measure of Medication Nonadherence in Hepatitis C Treatment.Digestive diseases and sciences · 2019Article
- Experiences with interferon-free hepatitis C therapies: addressing barriers to adherence and optimizing treatment outcomes.BMC health services research · 2019Article
- Development and Pilot-Testing of a Cognitive Behavioral Coping Skills Group Intervention for Patients with Chronic Hepatitis C.Contemporary clinical trials communications · 2017Article
- Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens.Medicine · 2016Article
- Does Hepatitis C Treatment Adherence Affect Risk of Liver Transplantation? A Historical Cohort Study.Journal of managed care & specialty pharmacy · 2016Observational
- Medication taking behaviors among breast cancer patients on adjuvant endocrine therapy.Breast (Edinburgh, Scotland) · 2015Article
- Is surviving enough? Coping and impact on activities of daily living among melanoma patients with lymphoedema.European journal of cancer care · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
goalsTo investigate the role of self-efficacy (SE) during hepatitis C virus (HCV) treatment.
backgroundAdherence to chronic HCV treatment is critical. SE is an important predictor of medication adherence in a number of chronic disease populations and medication regimens, but its role during HCV treatment remains unknown. STUDY: Data from the prospective Virahep-C study were analyzed to examine relationships between SE and patient-driven deviations (ie, missed doses measured using electronic pill caps, and nonpersistence) from adherence to HCV antiviral treatment. SE was measured using the 17-item HCV Treatment Self-Efficacy scale. This measure provides a global estimate of a patient's confidence to undergo and adhere to HCV treatment, and can estimate SE in 4 underlying domains: communication SE (ie, confidence to communicate with health care provider), physical coping SE (ie, confidence to cope with physical side effects), psychological coping SE (ie, confidence to cope with psychiatric side effects), and treatment adherence SE (ie, confidence to take all medications as prescribed and attend doctor visits). Generalized estimating equations and Cox proportional hazards models were used to assess associations between SE and missed doses and nonpersistence, respectively.
resultsSE was associated with being in a relationship, educated, privately insured, and less depressed. Higher communication SE at TW24 reduced the risk of missed doses between TW24 and TW48. Higher baseline treatment adherence SE reduced the likelihood of nonpersistence between baseline and TW24.
conclusionsSE's relationship to HCV treatment adherence has promising clinical and research implications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.